Tian-Li Wang

Three classes of genes mutated in colorectal cancers with chromosomal instability.

Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation.

Activation of mitogen-activated protein kinase is required for migration and invasion of placental site trophoblastic tumor.

Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma.

Digital karyotyping: an update of its applications in cancer.

Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas.

Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.

DNA copy numbers profiles in affinity-purified ovarian clear cell carcinoma.

Distinct DNA methylation profiles in ovarian serous neoplasms and their implications in ovarian carcinogenesis.

Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma.

Mutation of PPP2R1A: a new clue in unveiling the pathogenesis of uterine serous carcinoma.

Molecular genetic markers in female reproductive cancers.

ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers.

Mapping DNA Quantity into Electrophoretic Mobility through Quantum Dot Nanotethers for High-Resolution Genetic and Epigenetic Analysis.

Functional analysis of in-frame indel ARID1A mutations reveals new regulatory mechanisms of its tumor suppressor functions.

High level of chromosomal aberration in ovarian cancer genome correlates with poor clinical outcome.

The role of forkhead box Q1 transcription factor in ovarian epithelial carcinomas.

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.

Establishing isogenic inducible cell lines using founder reporter lines and recombinase-mediated cassette exchange.

The emerging roles of ARID1A in tumor suppression.

Roles of deletion of Arid1a, a tumor suppressor, in mouse ovarian tumorigenesis.

Notch3 interactome analysis identified WWP2 as a negative regulator of Notch3 signaling in ovarian cancer.

Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules.

Mevalonate Pathway Antagonist Suppresses Formation of Serous Tubal Intraepithelial Carcinoma and Ovarian Carcinoma in Mouse Models.

Inactivating ARID1A Tumor Suppressor Enhances TERT Transcription and Maintains Telomere Length in Cancer Cells.

Yes-associated protein impacts adherens junction assembly through regulating actin cytoskeleton organization.

PD-L1 Expression in Human Placentas and Gestational Trophoblastic Diseases.

Ovarian Cancer Chemoresistance Relies on the Stem Cell Reprogramming Factor PBX1.

Human transposon insertion profiling: Analysis, visualization and identification of somatic LINE-1 insertions in ovarian cancer.

Mutation of NRAS is a rare genetic event in ovarian low-grade serous carcinoma.

High grade serous ovarian carcinomas originate in the fallopian tube.

Detection and localization of surgically resectable cancers with a multi-analyte blood test.

Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers.

Inhibition of ovarian tumor cell invasiveness by targeting SYK in the tyrosine kinase signaling pathway.

Methylomic Analysis of Ovarian Cancers Identifies Tumor-Specific Alterations Readily Detectable in Early Precursor Lesions.

Fallopian Tube Lesions in Women at High Risk for Ovarian Cancer: A Multicenter Study.

PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8 T-cell Function.

Molecular Classification and Emerging Targeted Therapy in Endometrial Cancer.

Genomic characterization of genes encoding histone acetylation modulator proteins identifies therapeutic targets for cancer treatment.

Cytomorphologic and molecular analyses of fallopian tube fimbrial brushings for diagnosis of serous tubal intraepithelial carcinoma.

Uncovering the Role of N-Acetyl-Aspartyl-Glutamate as a Glutamate Reservoir in Cancer.

Loss of ARID1A in Tumor Cells Renders Selective Vulnerability to Combined Ionizing Radiation and PARP Inhibitor Therapy.

Clinicopathologic and Molecular Features of Paired Cases of Metachronous Ovarian Serous Borderline Tumor and Subsequent Serous Carcinoma.

Spleen tyrosine kinase activity regulates epidermal growth factor receptor signaling pathway in ovarian cancer.

-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma.

Epithelial Cells in Endometriosis and Adenomyosis Upregulate STING Expression.

Assessing aneuploidy with repetitive element sequencing.

Inactivation of Arid1a in the endometrium is associated with endometrioid tumorigenesis through transcriptional reprogramming.

Methylomic Landscapes of Ovarian Cancer Precursor Lesions.

Inhibition of the MYC-Regulated Glutaminase Metabolic Axis Is an Effective Synthetic Lethal Approach for Treating Chemoresistant Ovarian Cancers.

The Origin of Ovarian Cancer Species and Precancerous Landscape.

Correction: -mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma.

A novel human endometrial epithelial cell line for modeling gynecological diseases and for drug screening.

Mutation and methylation profiles of ectopic and eutopic endometrial tissues.

Development of small molecule inhibitors targeting PBX1 transcription signaling as a novel cancer therapeutic strategy.

Systems medicine dissection of chr1q-amp reveals a novel PBX1-FOXM1 axis for targeted therapy in multiple myeloma.

Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review.

Treating ARID1A mutated cancers by harnessing synthetic lethality and DNA damage response.

Targeting glutamine metabolism enhances responses to platinum-based chemotherapy in triple-negative breast cancers (TNBC).

Spatial Transcriptomic Analysis of Ovarian Cancer Precursors Reveals Reactivation of IGFBP2 during Pathogenesis.

Ultrasensitive detection of circulating LINE-1 ORF1p as a specific multi-cancer biomarker.

A novel human endometrial epithelial cell line for modeling gynecological diseases and for drug screening.